These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12981605)

  • 21. Relationship between chloramphenicol reductase activity and chloramphenicol resistance in Escherichia coli.
    MERKEL JR; STEERS E
    J Bacteriol; 1953 Oct; 66(4):389-96. PubMed ID: 13096493
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative in vitro acitvity of chloramphenicol and thiamphenicol on common aerobic and anaerobic gram-negative bacilli(Salmonella and Shigella excluded).
    Beers DV; Schoutens E; Vanderlinden MP; Yourassowsky E
    Chemotherapy; 1975; 21(2):73-81. PubMed ID: 1097209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chloramphenicol in maintaining the viability of Escherichia coli.
    EL-BAGOURY S; FLETCHER S; MORRISON RB
    Nature; 1956 Dec; 178(4548):1467. PubMed ID: 13387737
    [No Abstract]   [Full Text] [Related]  

  • 24. [Resistance of Escherichia coli to chloramphenicol and its simulants].
    SANTARATO R
    Arch Ital Sci Farmacol; 1952 Jul; 2(3):269. PubMed ID: 13008653
    [No Abstract]   [Full Text] [Related]  

  • 25. Chloramphenicol-sensitive DNA synthesis in normal and irradiated bacteria.
    DRAKULIC M; ERRERA M
    Biochim Biophys Acta; 1959 Feb; 31(2):459-63. PubMed ID: 13628674
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of structural elements of chloramphenicol in the molecular mechanism of its action].
    Telesnina GN; Novikova MA; Kolosov MN; Shemiakin MM
    Biokhimiia; 1968; 33(3):595-9. PubMed ID: 4878122
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of chloramphenicol and specific antiserum on the variability of the K 12 strain of Bact. coli.
    MANTEN A; ROWLEY D
    Br J Exp Pathol; 1953 Feb; 34(1):23-6. PubMed ID: 13032328
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibiotic resistance pattern among gram-negative bacteria isolated from raw milk in Multan.
    Farzana K; Jabeen F; Shah SN
    Pak J Pharm Sci; 2005 Jul; 18(3):11-6. PubMed ID: 16380338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the action of antibiotics on bacterial metabolism. II. Effect of dihydrostreptomycin, chloramphenicol and oxytetracycline upon the aerobic carbohydrate metabolism by Escherichia coli.
    KATAGIRI H; SUZUKI Y; TOCHIKURA T
    J Antibiot (Tokyo); 1960 May; 13():155-63. PubMed ID: 13830894
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative research with Escherichia coli on the problem of resistance formation in chloramphenicol therapy].
    HEISS F
    Zentralbl Bakteriol Orig; 1955 Nov; 164(1-5):227-9. PubMed ID: 13371855
    [No Abstract]   [Full Text] [Related]  

  • 31. The inhibition of adaptive enzyme formation in Escherichia coli by chloramphenicol.
    MARMUR J; SAZ AK
    Antibiot Chemother (Northfield); 1953 Jun; 3(6):613-7. PubMed ID: 24542687
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the mechanism of the loss of chloramphenicol resistance in Escherichia coli.
    HERRMANN EC; STEERS E
    J Bacteriol; 1953 Oct; 66(4):397-403. PubMed ID: 13096494
    [No Abstract]   [Full Text] [Related]  

  • 33. Some effects of 1-(2,4-Dichlorophenyl)-4-dimethylamino-methyl-1-nonen-3-one hydrochloride on Escherichia coli GK-19.
    Khachatourians GG; Holmlund PK; Dimmock JR
    J Pharm Sci; 1984 Jun; 73(6):803-8. PubMed ID: 6204038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sensitivity of chloramphenicol of monocytogenic cultures of Escherichia coli and Staphylococcus aureus].
    SANTARATO R
    Arch Ital Sci Farmacol; 1952 Jul; 2(3):268-9. PubMed ID: 13008652
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of the in vitro activity of some antimicrobial agents against selected gram-negative bacteria by EDTA-tromethamine.
    Farca AM; Nebbia P; Re G
    Vet Res Commun; 1993; 17(2):77-84. PubMed ID: 8212526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with maximal tolerated doses of antibiotics. II. Chloramphenicol, lincomycin, and other preparations].
    Vacek V; Hejzlar M; Stafová J
    Cas Lek Cesk; 1968; 107(44):1316-9. PubMed ID: 4971814
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of the isomers of chloramphenicol on growth and indole synthesis by Escherichia coli 7-4.
    McDOUGALL B; GIBSON F
    Aust J Exp Biol Med Sci; 1958 Jun; 36(3):245-9. PubMed ID: 13596271
    [No Abstract]   [Full Text] [Related]  

  • 38. The relation between lysogenicity in Escherichia coli and Bacillus megatherium to their susceptibilities to chloramphenicol and to streptomycin.
    COWLES PB; TREFFERS HP
    Yale J Biol Med; 1956 Sep; 29(1):50-3. PubMed ID: 13361275
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bacteriostasis and bactericidal action as alternative of antibacterial effect of chloramphenicol].
    FASSIN W; HENGEL R; KLEIN P
    Z Hyg Infektionskr; 1955; 141(4):363-75. PubMed ID: 13257408
    [No Abstract]   [Full Text] [Related]  

  • 40. Morning glory resin glycosides as modulators of antibiotic activity in multidrug-resistant gram-negative bacteria.
    Corona-Castañeda B; Pereda-Miranda R
    Planta Med; 2012 Jan; 78(2):128-31. PubMed ID: 22002849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.